Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAT Pilot: Rosuvastatin for H1N1
NCT01798602Phase 2Terminated
- Sponsor
- Canadian Critical Care Trials Group
- Start
- Dec 2009
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in H1N1 influenza (H1N1), sponsored by Canadian Critical Care Trials Group. Started Dec 2009; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
H1N1 influenza (H1N1)
Beyond the preview
Go deeper on NCT01798602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798602.